Sernova Biotherapeutics Inc (SEOVF) News
Follow Sernova Biotherapeutics Inc (SEOVF) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Sernova Biotherapeutics to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference
Jonathan Rigby and Will Rust, Ph.D., to Discuss Proposed Merger to Form BetaNova Biotherapeutics and Advance a Differentiated Type 1 Diabetes Cell-Replacement PlatformTORONTO and GERMANTOWN, Md., Sept. 25, 2026 (GLOBE NE
MNA | Sep 25, 2026, 11:01 AM UTC
H
Sernova, Seraxis sign definitive merger agreement
Sernova Biotherapeutics and Seraxis Holdings announced a definitive agreement to combine their technologies and businesses into BetaNova Biotherapeutics, a clinical-stage type 1 diabetes islet cell-replacement company.
MNA | Sep 08, 2026, 11:12 AM UTC